Friday, November 21, 2008 - 1:29AM EST

Clinical Trials

19. Neuropsychological impairment in obsessive-compulsive disorder--improvement over the course of cognitive behavioral treatment.

Author
Katrin Kuelz A; Riemann D; Halsband U; Vielhaber K; Unterrainer J; Kordon A; Voderholzer U;
Institution
Department of Psychiatry and Psychotherapy, University Hospital of Freiburg, Germany.
Journal
J Clin Exp Neuropsychol. 2006 Nov;28(8):1273-87.
Abstract URL
Click here to view abstract

20. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder.

Author
Greenberg BD; Malone DA; Friehs GM; Rezai AR; Kubu CS; Malloy PF; Salloway SP; Okun MS; Goodman WK; Rasmussen SA;
Institution
Department of Psychiatry and Human Behavior, Brown Medical School, Butler Hospital and Rhode Island Hospital, Providence, RI 02906, USA. bgreenberg@butler.org
Journal
Neuropsychopharmacology. 2006 Nov;31(11):2384-93. Epub 2006 Jul 19.
Abstract URL
Click here to view abstract

21. Response versus remission in obsessive-compulsive disorder.

Author
Simpson HB; Huppert JD; Petkova E; Foa EB; Liebowitz MR;
Institution
New York State Psychiatric Institute, New York, NY 10032, USA. simpson@nyspi.cpmc.columbia.edu
Journal
J Clin Psychiatry. 2006 Feb;67(2):269-76.
Abstract URL
Click here to view abstract

22. High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.

Author
Ninan PT; Koran LM; Kiev A; Davidson JR; Rasmussen SA; Zajecka JM; Robinson DG; Crits-Christoph P; Mandel FS; Austin C;
Institution
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1841 Clifton Road, Atlanta, GA 30329, USA. pninan@emory.edu
Journal
J Clin Psychiatry. 2006 Jan;67(1):15-22.
Abstract URL
Click here to view abstract
Pages: 1 2 3